On the hottest day on record for over 165 years, 30 CEOs and CFOs from many of the UK’s leading listed life science and healthcare companies made the journey to Westminster,…
Continue readingAXA Investment Managers, one of the world’s largest asset managers, offers customised investment solutions across all major asset classes and regions. The AXA Framlington Biotech fund provides long-term capital appreciation by investing principally in equity securities…
Continue readingRBC’s Corporate Banking Group provides leading financial services capabilities for global corporate and institutional clients. Alongside our Global Investment Banking colleagues, we leverage the global capabilities of RBC’s platform and work closely with…
Continue readingThe decision to take a company public is never taken lightly. For life science companies, however, that decision is further complicated by deciding where to list? Life science IPOs are back…
Continue readingLondon Stock Exchange is a diversified international exchange Group that sits at the heart of the world’s financial community. Through its markets, the Group offers international business, and investors, unrivalled access to Europe’s…
Continue readingVerseon was founded in 2002. Its proprietary drug discovery platform, developed entirely in-house, is the product of over ten years of research and development. The company’s platform is the first systematic, computationally-driven solution to…
Continue reading